As expected, a significant decrease in the expression of Atrogin1 (p < 0.001, Figure 4C) and MuRF1 (p < 0.001, Figure 4D) was observed in gastrocnemius tissues by the administration of MON at a level of 80 mg/kg to mice with DEX-induced muscle atrophy. This evidence concerns the gene FBXO32 and Atrophy.